Price $22.75 |
Market Cap
246.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
23.2
|
P/B
2.09
|
P/S
0.89
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
16.5
|
Op. Cash Flow
17.1K
|
FCF
1.3
|
|
Op. Margin
5.60%
|
Net Margin
3.00%
|
ROE
7.30%
|
ROI
10.20%
|
|
ROA
5.20%
|
EPS Growth
-65.80%
|
Current Ratio
2.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CYANOTECH CORP (CYAN) | $4.72 | - | - | 24.7M | Strong Buy |
| Rosetta Genomics Ltd. (USA) (ROSG) | $3.91 | - | - | 45.1M | Strong Buy |
| ImmuCell Corporation (ICCC) | $4.80 | - | - | 13.3M | Strong Buy |
| Prothena Corporation PLC (PRTA) | $18.22 | - | - | 601.1M | Strong Buy |
| ProPhase Labs Inc (PRPH) | $1.61 | - | - | 28.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
